Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB26FGSG6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,821
Award facts
- Contract value 100% obligated
- $7,820.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $7,820.92 to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg dose in 2 pen/mL formulation on November 10, 2025, with completion scheduled for November 12, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical will be delivered to the company's corporate office location in Conshohocken, Pennsylvania.
Cosentyx is a biologic immunosuppressant medication used to treat autoimmune conditions including psoriasis, psoriatic arthritis, and ankylosing spondylitis, representing a specialty pharmaceutical commodity within the Defense Health Agency's medical supply chain. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains a comprehensive federal contract portfolio supplying brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains to military and veteran healthcare systems. This delivery order exemplifies the company's ongoing role as a critical vendor for federal medical procurement through its prime global pharmaceutical support vehicle with DLA.
Quick answers
Who was awarded contract SPE2DB26FGSG6?
SPE2DB26FGSG6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 10, 2025.
How much is contract SPE2DB26FGSG6 worth?
The government has obligated $7,821 on SPE2DB26FGSG6.
Is contract SPE2DB26FGSG6 an order under another contract?
Yes. SPE2DB26FGSG6 is a delivery order under SPE2DB20D7059, an indefinite delivery contract.
Was contract SPE2DB26FGSG6 competed?
The extent of competition for SPE2DB26FGSG6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award